全球胰岛素笔市场：产业分析、规模、份额、成长、趋势和预测（2025-2032）

主要发现

• 胰岛素笔市场规模：84.069亿美元（2025年）
• 预计市场价值：145.958亿美元（2032年）
• 全球市场成长率：8.2%（2025年至2032年的复合年增长率）

胰岛素笔市场：报告范围

胰岛素笔是糖尿病患者用来注射胰岛素的医疗设备，与传统的管瓶和注射器注射方式相比，它更方便、更准确且易于使用。胰岛素笔市场包括可重复使用和一次性胰岛素笔，以及整合数位技术的智慧胰岛素笔。这些设备主要用于1型和第2型糖尿病患者的居家照护和临床治疗。推动市场成长的因素包括全球糖尿病盛行率的上升、对自主给药设备的需求不断增长，以及胰岛素笔设计和连接技术的进步。

市场成长动力

全球胰岛素笔市场受多种因素驱动，包括全球糖尿病盛行率的不断上升，以及对使用者友好且隐藏的胰岛素注射解决方案日益增长的需求。提高患者依从性、减轻注射疼痛以及提高给药准确性是推动其普及的关键优势。具有剂量追踪、蓝牙连接以及与糖尿病管理应用程式整合功能的智慧胰岛素笔的推出，将进一步推动市场成长。此外，新兴经济体政府为提高糖尿病认知度和扩大医疗保健覆盖范围而采取的倡议，也有助于提升市场渗透率。

市场限制

儘管成长前景光明，胰岛素笔市场仍面临成本、报销政策和设备召回等挑战。胰岛素笔（尤其是智慧胰岛素笔）价格高昂，限制了其在中低收入地区的普及。此外，各国报销政策不一致以及对不同类型胰岛素笔造成的浪费的担忧也阻碍了市场的成长。由于机械故障和给药失误导致的设备故障和产品召回也会影响使用者信心，并为製造商带来监管障碍。

市场机会

随着数位医疗的日益融合以及尚未开发的市场的不断扩张，胰岛素笔市场蕴藏着巨大的机会。糖尿病患者人数不断增长的新兴经济体拥有丰厚的成长潜力，尤其是在在地化生产和定价策略的推动下。医疗设备公司与数位健康平台合作开发具有即时血糖监测、剂量提醒和分析功能的智慧笔，将创造新的收益来源。此外，加大对微型化、环保和以患者为中心的设备研发投入，预计将推动技术创新和竞争优势。

本报告研究了全球胰岛素笔市场，评估了成长动力、趋势、机会和挑战等关键市场动态，并对市场结构提供了深入的见解。

目录

第一章执行摘要

第二章 市场概述

• 市场范围和定义
• 价值链分析
• 宏观经济因素
  • 全球GDP展望
  • 全球GDP展望
  • 全球经济成长预测
  • 全球都市化进程
  • 其他宏观经济因素
• 预测因子－相关性和影响力
• 评估COVID-19的影响
• PESTLE分析
• 波特五力分析
• 地缘政治紧张局势：其对市场的影响
• 监管和技术格局

第三章 市场动态

• 驱动程式
• 抑制因素
• 机会
• 趋势

第四章 价格趋势分析（2019-2032）

• 区域定价分析
• 价格：按细分市场
• 影响价格的因素

第五章 全球胰岛素笔市场展望：实际结果（2019-2024 年）与预测（2025-2032 年）

• 主要亮点
• 全球胰岛素笔市场展望：产品
  • 简介/主要发现
  • 市场规模绩效分析：依产品（2019-2024 年）
  • 按产品分類的当前市场规模预测（2025-2032）
    • 可重复使用的胰岛素笔
    • 抛弃式胰岛素笔
    • 智慧胰岛素笔
  • 市场吸引力分析：产品
• 全球胰岛素笔市场展望：适应症
  • 简介/主要发现
  • 市场规模绩效分析：按适应症（2019-2024）
  • 目前市场规模预测（依适应症划分）（2025-2032）
    • 1型糖尿病
    • 2型糖尿病
  • 市场吸引力分析：迹象
• 全球胰岛素笔市场展望：通路
  • 简介/主要发现
  • 市场规模绩效分析：按分销管道（2019-2024）
  • 按分销管道分類的当前市场规模预测（2025-2032）
    • 医院药房
    • 药局
    • 零售药局
    • 网路药局
  • 市场吸引力分析：分销管道

6. 全球胰岛素笔市场（按地区）展望

• 主要亮点
• 市场规模绩效分析：按地区（2019-2024）
• 目前市场规模预测：按地区（2025-2032）
  • 北美洲
  • 欧洲
  • 东亚
  • 南亚和大洋洲
  • 拉丁美洲
  • 中东和非洲
• 市场吸引力分析：地区

第七章。北美胰岛素笔市场展望：实际（2019-2024 年）与预测（2025-2032 年）

第 8 章。欧洲胰岛素笔市场展望：实际（2019-2024 年）与预测（2025-2032 年）

第九章东亚胰岛素笔市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 10 章。南亚和大洋洲胰岛素笔市场展望：实际（2019-2024 年）和预测（2025-2032 年）

第 11 章：拉丁美洲胰岛素笔市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 12 章。中东和非洲胰岛素笔市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第十三章竞争格局

• 市场占有率分析（2025年）
• 市场结构
  • 竞赛实力图谱
  • 竞争对手仪表板
• 公司简介
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Medtronic plc.
  • Ypsomed AG
  • Stevanato Group
  • Solteam Incorporation Co.

第十四章 附录

Persistence Market Research has recently released a comprehensive report on the worldwide market for insulin pens. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Insulin Pens Market Size (2025E): USD 8,406.90 Million
• Projected Market Value (2032F): USD 14,595.80 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 8.2%

Insulin Pens Market - Report Scope:

Insulin pens are medical devices used for the administration of insulin in diabetic patients, offering greater convenience, accuracy, and ease of use compared to traditional vial and syringe methods. The insulin pens market encompasses reusable and disposable pens, along with smart insulin pens integrated with digital technologies. These devices are primarily adopted by Type 1 and Type 2 diabetes patients for homecare and clinical use. Market growth is fueled by increasing global diabetes prevalence, rising demand for self-administration devices, and technological advancements in pen design and connectivity.

Market Growth Drivers:

The global insulin pens market is propelled by several key factors, including the growing incidence of diabetes worldwide and the increasing demand for user-friendly and discreet insulin delivery solutions. Enhanced patient adherence, reduced injection pain, and improved dosage accuracy are major benefits driving adoption. The introduction of smart insulin pens with dose tracking, Bluetooth connectivity, and integration with diabetes management apps further accelerates market growth. Additionally, government initiatives promoting diabetes awareness and the expansion of healthcare access in emerging economies contribute to increased market penetration.

Market Restraints:

Despite positive growth prospects, the insulin pens market faces challenges related to cost, reimbursement policies, and device recalls. High prices of insulin pens, especially smart variants, limit adoption in low- and middle-income regions. Furthermore, inconsistent reimbursement policies across different countries and concerns over insulin wastage with certain pen types hinder market growth. Device malfunctions and product recalls due to mechanical or dosage errors also impact user trust and present regulatory hurdles for manufacturers.

Market Opportunities:

The insulin pens market presents significant opportunities through advancements in digital health integration and expansion in untapped markets. Emerging economies with growing diabetic populations offer lucrative growth potential, especially with localized manufacturing and pricing strategies. Partnerships between medical device firms and digital health platforms to develop smart pens with real-time glucose monitoring, dose reminders, and analytics create new revenue streams. Moreover, increased investment in R\&D for miniaturized, eco-friendly, and patient-centric devices is expected to drive innovation and competitive advantage.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the insulin pens market globally?
• Which pen types and technologies are enhancing diabetes management in different healthcare settings?
• How are smart innovations and digital integration reshaping the insulin pens market landscape?
• Who are the major players in the insulin pens market and what strategies are being implemented for growth?
• What are the emerging trends and future outlook for the global insulin pens market?

Competitive Intelligence and Business Strategy:

Leading companies in the insulin pens market, including Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, and BD (Becton, Dickinson and Company), focus on product innovation, strategic collaborations, and expanding geographic reach. These firms are investing in advanced smart insulin pens and user-centric design features to enhance therapy compliance. Strategic partnerships with digital health companies and expansion into Asia Pacific and Latin American markets enable sustained growth. Furthermore, ongoing clinical research, patient support programs, and value-based care initiatives play a key role in market expansion and improved patient outcomes.

Key Companies Profiled:

• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi
• Medtronic plc.
• Ypsomed AG
• Stevanato Group
• Solteam Incorporation Co.

Insulin Pens Market Research Segmentation:

Product:

• Reusable Insulin Pens
• Disposable Insulin Pens
• Smart Insulin Pens

Indication:

• Diabetes Type I
• Diabetes Type II

Distribution Channel:

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Online Pharmacies

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Insulin Pens Market Snapshot 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Industry Developments and Key Market Events
• 1.5. Demand Side and Supply Side Analysis
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definitions
• 2.2. Value Chain Analysis
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Outlook
  • 2.3.2. Global GDP Outlook
  • 2.3.3. Global economic Growth Forecast
  • 2.3.4. Global Urbanization Growth
  • 2.3.5. Other Macro-economic Factors
• 2.4. Forecast Factors - Relevance and Impact
• 2.5. COVID-19 Impact Assessment
• 2.6. PESTLE Analysis
• 2.7. Porter's Five Forces Analysis
• 2.8. Geopolitical Tensions: Market Impact
• 2.9. Regulatory and Technology Landscape

3. Market Dynamics

• 3.1. Drivers
• 3.2. Restraints
• 3.3. Opportunities
• 3.4. Trends

4. Price Trend Analysis, 2019-2032

• 4.1. Region-wise Price Analysis
• 4.2. Price by Segments
• 4.3. Price Impact Factors

5. Global Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 5.1. Key Highlights
• 5.2. Global Insulin Pens Market Outlook: Product
  • 5.2.1. Introduction/Key Findings
  • 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
  • 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 5.2.3.1. Reusable Insulin Pens
    • 5.2.3.2. Disposable Insulin Pens
    • 5.2.3.3. Smart Insulin Pens
  • 5.2.4. Market Attractiveness Analysis: Product
• 5.3. Global Insulin Pens Market Outlook: Indication
  • 5.3.1. Introduction/Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
  • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 5.3.3.1. Diabetes Type I
    • 5.3.3.2. Diabetes Type II
  • 5.3.4. Market Attractiveness Analysis: Indication
• 5.4. Global Insulin Pens Market Outlook: Distribution Channel
  • 5.4.1. Introduction/Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2024
  • 5.4.3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 5.4.3.1. Hospital Pharmacies
    • 5.4.3.2. Drug Stores
    • 5.4.3.3. Retail Pharmacies
    • 5.4.3.4. Online Pharmacies
  • 5.4.4. Market Attractiveness Analysis: Distribution Channel

6. Global Insulin Pens Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
• 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia & Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 7.4.1. Reusable Insulin Pens
  • 7.4.2. Disposable Insulin Pens
  • 7.4.3. Smart Insulin Pens
• 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 7.5.1. Diabetes Type I
  • 7.5.2. Diabetes Type II
• 7.6. North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 7.6.1. Hospital Pharmacies
  • 7.6.2. Drug Stores
  • 7.6.3. Retail Pharmacies
  • 7.6.4. Online Pharmacies

8. Europe Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. Italy
  • 8.3.3. France
  • 8.3.4. U.K.
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Rest of Europe
• 8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 8.4.1. Reusable Insulin Pens
  • 8.4.2. Disposable Insulin Pens
  • 8.4.3. Smart Insulin Pens
• 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 8.5.1. Diabetes Type I
  • 8.5.2. Diabetes Type II
• 8.6. Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 8.6.1. Hospital Pharmacies
  • 8.6.2. Drug Stores
  • 8.6.3. Retail Pharmacies
  • 8.6.4. Online Pharmacies

9. East Asia Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 9.4.1. Reusable Insulin Pens
  • 9.4.2. Disposable Insulin Pens
  • 9.4.3. Smart Insulin Pens
• 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 9.5.1. Diabetes Type I
  • 9.5.2. Diabetes Type II
• 9.6. East Asia Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 9.6.1. Hospital Pharmacies
  • 9.6.2. Drug Stores
  • 9.6.3. Retail Pharmacies
  • 9.6.4. Online Pharmacies

10. South Asia & Oceania Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of SAO
• 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 10.4.1. Reusable Insulin Pens
  • 10.4.2. Disposable Insulin Pens
  • 10.4.3. Smart Insulin Pens
• 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 10.5.1. Diabetes Type I
  • 10.5.2. Diabetes Type II
• 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 10.6.1. Hospital Pharmacies
  • 10.6.2. Drug Stores
  • 10.6.3. Retail Pharmacies
  • 10.6.4. Online Pharmacies

11. Latin America Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of LATAM
• 11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 11.4.1. Reusable Insulin Pens
  • 11.4.2. Disposable Insulin Pens
  • 11.4.3. Smart Insulin Pens
• 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 11.5.1. Diabetes Type I
  • 11.5.2. Diabetes Type II
• 11.6. Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 11.6.1. Hospital Pharmacies
  • 11.6.2. Drug Stores
  • 11.6.3. Retail Pharmacies
  • 11.6.4. Online Pharmacies

12. Middle East & Africa Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Northern Africa
  • 12.3.4. Rest of MEA
• 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 12.4.1. Reusable Insulin Pens
  • 12.4.2. Disposable Insulin Pens
  • 12.4.3. Smart Insulin Pens
• 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 12.5.1. Diabetes Type I
  • 12.5.2. Diabetes Type II
• 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 12.6.1. Hospital Pharmacies
  • 12.6.2. Drug Stores
  • 12.6.3. Retail Pharmacies
  • 12.6.4. Online Pharmacies

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles
  • 13.3.1. Novo Nordisk A/S
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Product Portfolio/Offerings
    • 13.3.1.3. Key Financials
    • 13.3.1.4. SWOT Analysis
    • 13.3.1.5. Company Strategy and Key Developments
  • 13.3.2. Eli Lilly and Company
  • 13.3.3. Sanofi
  • 13.3.4. Medtronic plc.
  • 13.3.5. Ypsomed AG
  • 13.3.6. Stevanato Group
  • 13.3.7. Solteam Incorporation Co.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations